708 related articles for article (PubMed ID: 29486333)
1. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes.
Chao PC; Li Y; Chang CH; Shieh JP; Cheng JT; Cheng KC
Biomed Pharmacother; 2018 May; 101():155-161. PubMed ID: 29486333
[TBL] [Abstract][Full Text] [Related]
2. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of high fat diet fed and low dose streptozotocin induced diabetic Wistar rat model.
Wickramasinghe ASD; Attanayake AP; Kalansuriya P
J Pharmacol Toxicol Methods; 2022; 113():107144. PubMed ID: 34896263
[TBL] [Abstract][Full Text] [Related]
4. Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes.
Wilson RD; Islam MS
Pharmacol Rep; 2012; 64(1):129-39. PubMed ID: 22580529
[TBL] [Abstract][Full Text] [Related]
5. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Gadbois TM; Reaven GM
Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
[TBL] [Abstract][Full Text] [Related]
6. [Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus].
Wang B; Li Y; Liu X; Liu S; Sun C
Wei Sheng Yan Jiu; 2011 Jan; 40(1):99-102, 106. PubMed ID: 21434325
[TBL] [Abstract][Full Text] [Related]
7. Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.
Niu HS; Ku PM; Niu CS; Cheng JT; Lee KS
Drug Des Devel Ther; 2015; 9():5625-32. PubMed ID: 26508837
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a rat model of type II diabetic neuropathic pain.
Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ
Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogen‑activated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin.
Zhuo J; Zeng Q; Cai D; Zeng X; Chen Y; Gan H; Huang X; Yao N; Huang D; Zhang C
Mol Med Rep; 2018 Apr; 17(4):5132-5142. PubMed ID: 29393432
[TBL] [Abstract][Full Text] [Related]
10. Nongenetic mouse models of non-insulin-dependent diabetes mellitus.
Luo J; Quan J; Tsai J; Hobensack CK; Sullivan C; Hector R; Reaven GM
Metabolism; 1998 Jun; 47(6):663-8. PubMed ID: 9627363
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-stabilized selenium nanoparticles alleviate cardio-hepatic damage in type 2 diabetes mellitus model via regulation of caspase, Bax/Bcl-2, and Fas/FasL-pathway.
Mohamed AA; Khater SI; Hamed Arisha A; Metwally MMM; Mostafa-Hedeab G; El-Shetry ES
Gene; 2021 Feb; 768():145288. PubMed ID: 33181259
[TBL] [Abstract][Full Text] [Related]
13. A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.
Velagic A; Li M; Deo M; Li JC; Kiriazis H; Donner DG; Anderson D; De Blasio MJ; Woodman OL; Kemp-Harper BK; Qin CX; Ritchie RH
Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H241-H257. PubMed ID: 36607798
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy.
Zhou W; Ye S
Cell Biol Int; 2018 Sep; 42(10):1282-1291. PubMed ID: 29908010
[TBL] [Abstract][Full Text] [Related]
15. Eugenosedin-A improves glucose metabolism and inhibits MAPKs expression in streptozotocin/nicotinamide-induced diabetic rats.
Shen KP; Lin HL; Yen HW; Hsieh SL; An LM; Wu BN
Kaohsiung J Med Sci; 2018 Mar; 34(3):142-149. PubMed ID: 29475461
[TBL] [Abstract][Full Text] [Related]
16. Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin.
Mansor LS; Gonzalez ER; Cole MA; Tyler DJ; Beeson JH; Clarke K; Carr CA; Heather LC
Cardiovasc Diabetol; 2013 Sep; 12():136. PubMed ID: 24063408
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats.
Lee WK; Kao ST; Liu IM; Cheng JT
Horm Metab Res; 2007 May; 39(5):347-54. PubMed ID: 17533576
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats.
Jiao Y; Wang X; Jiang X; Kong F; Wang S; Yan C
J Ethnopharmacol; 2017 Mar; 199():119-127. PubMed ID: 28163112
[TBL] [Abstract][Full Text] [Related]
19. Isoflurane aggravates peripheral and central insulin resistance in high-fat diet/streptozocin-induced type 2 diabetic mice.
Fang X; Xia T; Xu F; Wu H; Ma Z; Zhao X; Gu X
Brain Res; 2020 Jan; 1727():146511. PubMed ID: 31672472
[TBL] [Abstract][Full Text] [Related]
20. Effects of crocin and voluntary exercise, alone or combined, on heart VEGF-A and HOMA-IR of HFD/STZ induced type 2 diabetic rats.
Ghorbanzadeh V; Mohammadi M; Dariushnejad H; Chodari L; Mohaddes G
J Endocrinol Invest; 2016 Oct; 39(10):1179-86. PubMed ID: 27094045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
